@article{ATM30054,
author = {Bumhee Yang and Hayoung Choi and Sang-Heon Kim and Ho Joo Yoon and Hyun Lee},
title = {How will nanotechnology lead to better control of asthma?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {20},
year = {2019},
keywords = {},
abstract = {Asthma is a common inflammatory disease of the lungs characterized by reversible airway obstruction, bronchial hyper-responsiveness, and chronic airway inflammation (1). The most widely used therapies for asthma include inhaled corticosteroids and bronchodilators (short- or long-acting β2-adrenergic agonists or muscarinic antagonists). Although most patients with asthma respond well to inhaled corticosteroids, asthma control is poor in some patients who require maximal dosages (2).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/30054}
}